ASX Share rice
Mon 17 May 2021 - 05:22:am (Sydney)

IMU Share Price

IMUGENE LIMITEDIMUPharmaceuticals, Biotechnology & Life Sciences

IMU Company Information


Imugene Limited





GIC Industry:


GIC Sub Industry:



37 Bligh Street Sydney NSW Australia 2000


61 3 9824 5254

Exec. Chairman:

Mr. Paul Edward-Alexander Hopper

CEO, MD & Exec. Director:

Ms. Leslie Chong


Dr. Nicholas J. Ede

CFO & Joint Company Sec.:

Mr. Phillip Allen Hains

Chief Medical Officer:

Dr. Rita Laeufle M.D., Ph.D.

Joint Company Sec.:

Mr. Justyn Peter Stedwell B.Com., B.Com

Company Overview:

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF-33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.

IMU Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


IMU CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


IMU Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


Interest Expense:


Total Revenue:


IMU Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities (Other):


Non Current Liabilities Total:


IMU Share Price History

IMU News

11 Dec, 2020
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
10 Sep, 2020
Leslie Chong became the CEO of Imugene Limited (ASX:IMU) in 2016, and we think it's a good time to look at the...
23 May, 2020
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...